Cargando…

Favipiravir: Drug fever: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103138/ http://dx.doi.org/10.1007/s40278-021-95487-7

Ejemplares similares

Favipiravir: Hyperuricaemia: case report
Publicado: (2021)

Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
por: Tawara, Junsuke, et al.
Publicado: (2021)

Favipiravir/methotrexate interaction: Hepatotoxicity due to drug interaction: case report
Publicado: (2021)

Favipiravir: Fever and elevated uric acid level following off-label therapy: 2 case reports
Publicado: (2021)

A Favipiravir-induced Fever in a Patient with COVID-19
por: Kurita, Takashi, et al.
Publicado: (2020)

Favipiravir: Various toxicities: 3 case reports
Publicado: (2022)

Favipiravir: Erythema and transaminase elevation: case report
Publicado: (2022)

A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test
por: Murai, Yushi, et al.
Publicado: (2021)

Favipiravir/loxoprofen/paracetamol: Symmetrical drug-related intertriginous and flexural exanthema: case report
Publicado: (2021)

Favipiravir: Acute generalised exanthematous pustulosis: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Various toxicities: 7 case reports
Publicado: (2022)

Favipiravir/voriconazole: Hyperuricaemia, transaminitis and off-label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Hypoglycaemia and off label use: case report
Publicado: (2021)

Favipiravir: Liver injury following an off-label use: case report
Publicado: (2021)

Favipiravir: Acute pancreatitis following an off-label use: case report
Publicado: (2021)

Favipiravir: Lack of efficacy following off-label treatment: case report
Publicado: (2021)

Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022)

Favipiravir: Acute psychosis following off-label use: case report
Publicado: (2022)

Favipiravir/methylprednisolone: Off-label use and lack of efficacy: case report
Publicado: (2022)

Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)
por: Song, Rui, et al.
Publicado: (2019)

Favipiravir: Bilateral foot ulcers, vasculitis and off-label use : case report
Publicado: (2021)

Colchicine/favipiravir/prednisolone: Lack of efficacy and off label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Favipiravir‐induced nephrotoxicity in a patient with COVID‐19: A case report
por: Abdelbary, Asmaa A., et al.
Publicado: (2021)

Favipiravir/levofloxacin/paracetamol: Severe thrombocytopenia and off-label use: case report
Publicado: (2021)

Ceftriaxone/favipiravir/vancomycin: Lack of efficacy and off-label use: case report
Publicado: (2022)

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
por: Takoi, Hiroyuki, et al.
Publicado: (2020)

Favipiravir: Contraindicated drug administered during pregnancy and patent foramen ovale following in-utero exposure: 2 case reports
Publicado: (2022)

Toxic hepatitis case with prolonged jaundice due to Favipiravir
por: Yolacan, Ramazan, et al.
Publicado: (2022)

Favipiravir: Lack of efficacy secondary to off label use in COVID-19: Case report: case report
Publicado: (2021)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

Favipiravir: Hyperuricaemia and acute gouty arthritis following off-label use: case report
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine: Ventricular tachycardia and off-label use: 2 case reports
Publicado: (2020)

Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report
Publicado: (2022)

Favipiravir: Hyperuricaemia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient
por: Jadeja, Dhigishaba M, et al.
Publicado: (2021)

Favipiravir/meropenem/vancomycin: Cholestatic liver injury following off-label use: case report
Publicado: (2021)

Ciclesonide/favipiravir/lopinavir/ritonavir: Off-label use, pancytopenia and liver dysfunction: case report
Publicado: (2021)

Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020)

Favipiravir: Lack of efficacy during the treatment with SARS-CoV-2 pneumonia: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_soj8ne2tj0ff0do10n801r0fl2